Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19 Latest  Aug 08, 2020  3 years, 8 months, 1 week, 3 days, 22 hours, 11 minutes ago

COVID-19 Latest: Mount Sinai Urologists Advocate That Men With Prostate Cancer Be Screened For COVID-19 Routinely Due To Severity And Mortality Risk

COVID-19 Latest: Mount Sinai Urologists Advocate That Men With Prostate Cancer Be Screened For COVID-19 Routinely Due To Severity And Mortality Risk
Source: COVID-19 Latest  Aug 08, 2020  3 years, 8 months, 1 week, 3 days, 22 hours, 11 minutes ago
COVID-19 Latest: A team of medical researchers from the Department of Urology and the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York  in a review paper that focuses on the two diseases (Prostrate Cancer And COVID-19) advocate that  males with prostate cancer should be routinely tested for COVID-19.


 
Their research review was published in the journal: Nature Communications Biology. https://www.nature.com/articles/s42003-020-1088-9
 
Lead researcher Dr Dimple Chakravarty, MD, from the Tisch Cancer Institute at Mount Sinai in New York City told Thailand Medical News, "The particular vulnerability of older men to COVID-19 compels us to advocate for routine screening of SARS-CoV-2 infections in prostate cancer patients."
 
This call is however not in line with major cancer groups such as the American Cancer Society and the American Society of Clinical Oncology, who do not advise COVID-19 testing on the singular basis of a person having a cancer.
 
The Mount Sinai team also revealed previously unpublished data from their health system on prostate cancer and COVID-19 mortality. From March 1 to April 26, the system had 9,648 COVID-19-positive patients, of which 5238 (54.3%) were male, including 114 (2.2%) with a previous diagnosis of prostate cancer.
 
It was observed in this COVID cohort, the mortality rate among patients with prostate cancer (n = 27) was nearly double of that among all male patients with a malignancy (n = 43) other than prostate cancer (23.7% vs. 12.7%; P < .01).
 
Some medical experts are however advising that these are "preliminary" data and "caution is warranted since confounding is likely massive."
 
Many also do not agree with the proposal that all patients with prostate cancer should be tested for COVID-19.
 
Some said